CBD US Senate bill would finally allow CBD in food and drinks A bipartisan group of US senators want to mandate the FDA to regulate CBD as a dietary supplement to improve the hemp industry and... Jared GnamMay 19, 2021
Industry update Hexo to enter Europe with $265M Zenabis acquisition Hexo says the all-stock deal will gives it a top-3 spot in the Canadian cannabis market and a key foothold in Europe Jared GnamFebruary 16, 2021
Industry update Jazz Pharma to buy CBD drugmaker GW Pharma for US$7.2B Shares of GW skyrocketed nearly 50% after the companies revealed the largest acquisition in the cannabis sector to date Jared GnamFebruary 4, 2021
Extraction Canopy’s GW Pharma lawsuit could be trouble for US extractors Canopy has a fair shot at winning its suit against GW, but the case might not have a widespread effect on US pot extractors,... Jared GnamDecember 24, 2020
Industry update GW Pharma shares soar 21% on rising revenues The cannabinoid drugmaker also launched a Phase 3 trial for a multiple sclerosis treatment Jared GnamNovember 3, 2020
The weed wire FDA’s new draft guidelines could speed up CBD drug approvals As industry players await full regulations, the US federal agency continues to slowly open up the CBD market Jared GnamSeptember 29, 2020
The weed wire U.K. reduces wait times for patients accessing cannabis-based medicines Changes to U.K. laws mean licensed wholesalers can import and store larger quantities of weed Michelle GamageMarch 2, 2020
Medical and Pharmaceutical GW Pharma asks FDA to approve Epidiolex to treat a third epileptic disorder The cannabis-based medicine could treat seizures associated with Tuberous Sclerosis Complex Michelle GamageFebruary 3, 2020
CBD US House introduces bill to allow sale of CBD-infused food and drink The bipartisan bill would allow for hemp-derived CBD to be sold as a dietary supplement Jared GnamJanuary 17, 2020
Canada Industry experts say more executive diversity will improve weed’s bottom line Without representation cannabis companies will miss out on key market opportunities Michelle GamageJanuary 15, 2020